Journal rankings · indicator year 2013
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Domain ranking · 2013
Health Sciences journal rankings 2013
4,129 ranked journals · Domain
Health Sciences has 4,129 ranked journals in 2013. The median journal has an OJR of 0.74, below the world average of 1.00, down 0.04 on 2012; Q1 starts at OJR 1.31. The top three are CA A Cancer Journal for Clinicians, New England Journal of Medicine, and Clinical Microbiology Reviews.
Ranks and citation indicators: 2013. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2010–2012, the window the 2013 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Fields in Health Sciences (5)
Up to All journals4,129 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2012. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2010–2012, the window the 2013 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2010–2012 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2004 to 2013. | Compare |
|---|---|---|---|---|---|---|---|
1CA A Cancer Journal for CliniciansOAWiley · United States | 73.88Q1 | 210.23 13.30 up from 2012 | 68 | 100% | $4,330 | ||
2New England Journal of MedicineMassachusetts Medical Society · United States | 14.07Q1 | 27.60 1.18 up from 2012 | 2,855 | 38% | — | ||
3Clinical Microbiology ReviewsAmerican Society for Microbiology · United States | 12.58Q1 | 23.05 2.01 down from 2012 | 95 | 98% | — | ||
4Archives of General PsychiatryAmerican Medical Association · United States | 8.42Q1 | 14.43 1.18 down from 2012 | 461 | 0% | — | ||
5Endocrine ReviewsOxford University Press · United States | 7.95Q1 | 15.86 1.41 up from 2012 | 107 | 51% | $3,750 | ||
6The LancetElsevier BV · Netherlands | 7.95Q1 | 14.59 1.57 up from 2012 | 3,488 | 45% | $7,890 | ||
7Cancer CellCell Press · Netherlands | 7.42Q1 | 20.03 0.05 down from 2012 | 495 | 100% | $10,400 | ||
8European Heart JournalOxford University Press · United Kingdom | 6.92Q1 | 16.30 1.86 up from 2012 | 1,066 | 36% | $5,922 | ||
9The Lancet NeurologyElsevier BV · Netherlands | 6.82Q1 | 15.26 1.30 down from 2012 | 514 | 43% | $7,280 | ||
10The Lancet OncologyElsevier BV · United Kingdom | 6.24Q1 | 15.89 1.80 up from 2012 | 807 | 16% | $7,280 | ||
11CirculationLippincott Williams & Wilkins · United States | 6.21Q1 | 13.43 1.41 down from 2012 | 2,734 | 19% | — | ||
12Journal of Occupational Health PsychologyAmerican Psychological Association · United States | 6.08Q1 | 5.00 0.56 down from 2012 | 117 | 10% | — | ||
13Journal of the American College of CardiologyElsevier BV · United States | 5.81Q1 | 13.43 0.70 up from 2012 | 2,108 | 99% | $7,166 | ||
14PLoS MedicineOAPublic Library of Science · United States | 5.77Q1 | 12.09 0.18 down from 2012 | 603 | 100% | $6,460 | ||
15Work and OccupationsSAGE Publishing · United States | 5.68Q1 | 4.03 1.55 up from 2012 | 52 | 19% | $3,900 | ||
16Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 5.55Q1 | 13.09 0.59 down from 2012 | 2,937 | 8% | — | ||
17Milbank QuarterlyWiley · United States | 5.52Q1 | 6.49 0.38 up from 2012 | 81 | 90% | $4,430 | ||
18Nature MedicineNature Portfolio · United States | 5.15Q1 | 12.68 2.27 up from 2012 | 1,433 | 34% | $12,690 | ||
19Natural Product ReportsRoyal Society of Chemistry · United Kingdom | 5.15Q1 | 11.32 0.22 up from 2012 | 234 | 12% | — | ||
20Progress in Retinal and Eye ResearchElsevier BV · Netherlands | 5.12Q1 | 11.08 1.34 up from 2012 | 95 | 45% | $6,710 | ||
21Alzheimer s & DementiaWiley · United States | 4.89Q1 | 12.15 0.51 down from 2012 | 345 | 24% | $4,200 | ||
22Journal of Mixed Methods ResearchSAGE Publishing · United States | 4.84Q1 | 3.32 0.41 up from 2012 | 68 | 30% | $3,900 | ||
23European UrologyElsevier BV · Switzerland | 4.78Q1 | 10.01 0.12 down from 2012 | 1,000 | 11% | $5,250 | ||
24BrainOxford University Press · United Kingdom | 4.71Q1 | 11.37 0.72 up from 2012 | 970 | 53% | $5,570 | ||
25Annals of NeurologyWiley · United States | 4.64Q1 | 10.86 0.36 up from 2012 | 757 | 38% | $4,700 | ||
26Diabetes CareAmerican Diabetes Association · United States | 4.47Q1 | 9.06 0.42 down from 2012 | 1,852 | 96% | — | ||
27Seminars in Liver DiseaseThieme Medical Publishers (Germany) · United States | 4.33Q1 | 7.51 2.25 down from 2012 | 114 | 27% | — | ||
28PLoS PathogensOAPublic Library of Science · United States | 4.17Q1 | 9.81 0.15 down from 2012 | 1,729 | 100% | $3,043 | ||
29The American Journal of Sports MedicineSAGE Publishing · United States | 4.08Q1 | 6.98 0.29 up from 2012 | 923 | 12% | $4,400 | ||
30JNCI Journal of the National Cancer InstituteOxford University Press · United States | 3.99Q1 | 11.52 0.67 up from 2012 | 643 | 50% | $5,436 | ||
31Journal of Visual LiteracyTaylor & Francis · United States | 3.96Q1 | 2.40 1.73 up from 2012 | 31 | 0% | — | ||
32AutophagyTaylor & Francis · United States | 3.93Q1 | 9.31 0.12 up from 2012 | 320 | 99% | — | ||
33Cochrane Database of Systematic ReviewsElsevier BV · United Kingdom | 3.93Q1 | 7.73 1.03 up from 2012 | 1,805 | 48% | $5,100 | ||
34GastroenterologyElsevier BV · United States | 3.91Q1 | 8.41 0.34 down from 2012 | 1,771 | 38% | $4,180 | ||
35BMC MedicineOABioMed Central · United Kingdom | 3.86Q1 | 8.83 2.23 down from 2012 | 398 | 100% | $4,190 | ||
36Journal of Medical Internet ResearchOAJMIR Publications · Germany | 3.85Q1 | 8.02 1.01 up from 2012 | 375 | 100% | $2,950 | ||
37American Journal of Respiratory and Critical Care MedicineAmerican Thoracic Society · United States | 3.81Q1 | 7.99 0.11 up from 2012 | 1,573 | 33% | — | ||
38JACC: Cardiovascular InterventionsElsevier BV · United States | 3.77Q1 | 7.40 1.07 up from 2012 | 617 | 100% | $5,000 | ||
39Acta NeuropathologicaSpringer Science+Business Media · Germany | 3.74Q1 | 11.15 1.33 up from 2012 | 411 | 60% | $4,990 | ||
40Annals of the Rheumatic DiseasesBMJ · United Kingdom | 3.70Q1 | 8.38 1.06 down from 2012 | 1,339 | 12% | $4,870 | ||
41Sports MedicineSpringer Science+Business Media · Switzerland | 3.69Q1 | 6.22 1.00 down from 2012 | 236 | 20% | $5,790 | ||
42Seminars in Cancer BiologyElsevier BV · United States | 3.69Q1 | 11.09 1.95 up from 2012 | 170 | 30% | $6,060 | ||
43PEDIATRICSAmerican Academy of Pediatrics · United States | 3.69Q1 | 6.73 0.37 down from 2012 | 2,510 | 19% | — | ||
44The Lancet Infectious DiseasesElsevier BV · Netherlands | 3.62Q1 | 9.62 2.92 down from 2012 | 564 | 39% | $7,280 | ||
45Medical Image AnalysisElsevier BV · United Kingdom | 3.61Q1 | 5.35 0.12 up from 2012 | 246 | 50% | $4,170 | ||
46Annals of Internal MedicineAmerican College of Physicians · United States | 3.61Q1 | 8.56 1.42 up from 2012 | 1,324 | 11% | — | ||
47Advances in NutritionElsevier BV · United States | 3.61Q1 | 6.42 1.30 up from 2012 | 166 | 100% | $5,200 | ||
48American Journal of Community PsychologyWiley · Netherlands | 3.60Q1 | 2.84 0.28 down from 2012 | 263 | 25% | $3,620 | ||
49Clinical Infectious DiseasesOxford University Press · United States | 3.55Q1 | 8.61 0.77 up from 2012 | 2,124 | 44% | $4,763 | ||
50American Journal of Clinical NutritionElsevier BV · United States | 3.55Q1 | 7.70 0.44 down from 2012 | 1,276 | 99% | $5,200 |
Fields of Health Sciences, compared.
Journals
Citations made in 2013. Corpus-wide, 76.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
1,258 additional Health Sciences journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2010–2012, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2013. Publication window: 2010–2012. How these summaries are calculated
- Ranked journals
- 4,129
- Window papers (baseline)
- 2,204,628 +16.8% from indicator year 2010
- Median OJR
- 0.741 -3.4% from indicator year 2010
- Rising journals (2025)
- 464
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2010–2012 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 2,007 | 2,150 | 2,285 | 2,374 | 2,486 | 2,626 | 2,757 | 2,922 | 3,062 | 3,193 | 3,364 | 3,591 | 3,809 | 4,129 | 4,361 | 4,544 | 4,757 | 4,979 | 5,239 | 5,390 | 5,462 | 5,563 | 5,606 | 5,618 | 5,549 | 5,406 | |
| Window papers (baseline) | 813,419 | 909,304 | 974,228 | 1,051,248 | 1,094,845 | 1,200,886 | 1,317,521 | 1,455,690 | 1,577,275 | 1,733,757 | 1,887,930 | 2,035,231 | 2,126,669 | 2,204,628 | 2,320,572 | 2,437,477 | 2,534,543 | 2,585,157 | 2,649,222 | 2,728,712 | 2,846,138 | 3,078,764 | 3,332,730 | 3,490,788 | 3,507,496 | 3,550,948 | |
| Median OJR | 0.50 | 0.53 | 0.56 | 0.59 | 0.61 | 0.63 | 0.6778 | 0.70 | 0.726 | 0.748 | 0.767 | 0.773 | 0.78 | 0.741 | 0.76 | 0.750 | 0.737 | 0.727 | 0.71 | 0.725 | 0.735 | 0.680 | 0.67 | 0.6776 | 0.681 | 0.69 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 3.3% | 4,151 journals |
| Retracted papers per 1,000 | Pooled rate: 1.372 per 1,000 | 4,101 journals |
| Output growth | Median: -6.3% | 5,009 journals |
| Open access share | Median: 100.0% | 5,406 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,090 | 2,959 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 20.2% | 5,241 journals |
| Review share | Median: 2.7% | 5,406 journals |
| Articles-only OJR | Median: 0.70 | 5,372 journals |
| Uncited share | Median: 37.7% | 5,406 journals |
| Citation concentration | Median: 46.2% | 5,398 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.